MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Aduro BioTech Company Profile (NASDAQ:ADRO)

Consensus Ratings for Aduro BioTech (NASDAQ:ADRO) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $24.17 (122.32% upside)

Analysts' Ratings History for Aduro BioTech (NASDAQ:ADRO)
Show:
DateFirmActionRatingPrice TargetActions
5/16/2016Roth CapitalReiterated RatingBuy$46.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016Leerink SwannReiterated RatingOutperform$48.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016FBR & Co.Lower Price TargetOutperform$30.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Bank of AmericaDowngradeBuy -> Underperform$32.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016William BlairInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015OppenheimerDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha